Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world. The CARB-X portfolio is the world’s most scientifically diverse, early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products. CARB-X is the only global partnership that integrates solutions for the prevention, diagnosis and treatment of life-threatening bacterial infections, translating innovation from basic research to first-in-human clinical trials.
Learn more about the organization through their website: https://carb-x.org/
Community Engagement for Antimicrobial Resistance (CE4AMR)
Community Engagement for Antimicrobial Resistance (CE4AMR) is a network of researchers and practitioners who use, or are interested in using, community engagement – in particular participatory and creative approaches – to tackle Antimicrobial Resistance (AMR) in low- and middle-income countries (LMICs). CE4AMR brings together artists, health professionals, engineers, social and environmental scientists and arts and humanities researchers to create a cross-disciplinary platform through which to share ideas, tackle research gaps and develop new skill sets to address AMR at community level. Rather than regarding community engagement approaches as “add-ons” to research, CE4AMR views them as integral to meeting global recommendations on tackling AMR as stipulated by the World Health Organization and country-specific AMR action plans.
Learn more about the organization through their website: https://ce4amr.leeds.ac.uk/